ClinVar Miner

Submissions for variant NM_000138.5(FBN1):c.5031C>T (p.Asp1677=)

dbSNP: rs1597545860
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV001425549 SCV001628179 likely benign Marfan syndrome; Familial thoracic aortic aneurysm and aortic dissection 2020-11-04 criteria provided, single submitter clinical testing
Fulgent Genetics, Fulgent Genetics RCV002507501 SCV002806684 likely benign Ectopia lentis 1, isolated, autosomal dominant; Marfan syndrome; MASS syndrome; Stiff skin syndrome; Weill-Marchesani syndrome 2, dominant; Acromicric dysplasia; Geleophysic dysplasia 2; Progeroid and marfanoid aspect-lipodystrophy syndrome 2021-11-07 criteria provided, single submitter clinical testing
Ambry Genetics RCV003169147 SCV003863103 likely benign Familial thoracic aortic aneurysm and aortic dissection 2023-02-12 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
All of Us Research Program, National Institutes of Health RCV004003012 SCV004831078 uncertain significance Marfan syndrome 2023-06-26 criteria provided, single submitter clinical testing This variant is located in the FBN1 protein. To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with FBN1-related disorders in the literature. This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.